Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
3 Promising Gene Therapy Stocks
Article By:
Tarun Chandra, CFA
Saturday, May 25, 2019 9:45 PM EDT
Investor interest in gene therapy companies has been on the rise. Here is a look at 3 promising small cap gene therapy companies.
In this article: BOLD, VYGR, QURE Also: SRPT, PTCT, BLUE, ONCE, EDIT, NTLA, CRSP, RGNX, SLDB, FIXX, MGTX, NVS, RHHBY, GOOG, ACAD, ARNA, ARRY, CBPO, PCRX, AMRN, SAGE, MRNA, GWPH, ASND, RARX, BHVN, MRTX, DNLI, CHRS, MDCO, ARWR, ZIOP, TGTX, PTLA, GBT, AXSM
Voyager Sinks After Sanofi Opts Out Of Parkinson's Program
Article By:
The Fly
Monday, October 30, 2017 6:57 PM EDT
Shares of Voyager Therapeutics are down 19% in after-hours trading to $18.50 after the company announced that Sanofi Genzyme decided not to exercise its rights to the VY-AADC program for advanced Parkinson's disease.
The FDA: Small-Cap Catalyst Or Small-Cap Killer?
Article By:
Paradigm Press
Friday, December 16, 2016 9:37 AM EDT
This particular bureaucracy neither gives nor takes. Data do. If a drug works, the company that develops it will do well. If a drug doesn’t work, the company that develops it had better have a diversified pipeline.
Morning Call For Thursday, Dec. 8
Article By:
Jim Van Meerten
Thursday, December 8, 2016 11:10 AM EDT
The weaker dollar has boosted crude oil prices with Jan WTI crude up +0.78%, which has also lifted energy producing stocks. Stock markets around the world also rose on signs of economic strength in China after China Nov exports unexpectedly rose.